Answer
No. Its UK indication is restricted to genetically confirmed FCS meeting specific severity and response criteria.
Sources for this answer
- Waylivra (volanesorsen) — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.